• Signant Strengthens Digitally Optimized Trial Strategy with Delivery of Study Supplies Direct to Patients’ Homes

    Jul 18, 2022, 09:42 by
    Signant Health, the leader in evidence generation for modern clinical trials, announced today enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution. With Signant SmartSignals RTSM, customers can leverage additional benefits of digitally optimized trials by delivering study supplies directly to participants’ homes.
    Full story
  • Biotium Introduces New Line of Antibodies for Exosome Detection

    Jul 18, 2022, 09:42 by
    Biotium, a leading supplier and inventor of fluorescent cellular probes for life science research, announces the release of new ExoBrite™ Antibody Conjugates
    Full story
  • Milestones Easier To Meet With Integrated Clinical Trials Management System

    Jul 14, 2022, 01:00 by User Not Found
    Clinical Research News | Until recently, clinical study teams at the Medical University of South Carolina had no system for registering participants, keeping track of upcoming study visits, or what to invoice when on industry-sponsored projects. All that is changing with implementation of a clinical trials management system, fully integrated with the university’s Research Integrated Network of Systems, in mandatory use since March 2022 for all new trials undertaken across campus.
    Full story
  • Tufts Study Provides ‘First Hard Metrics’ Around Decentralized Clinical Trials

    Jul 13, 2022, 01:00 by User Not Found
    Clinical Research News | Decentralized clinical trials can deliver a higher “expected net present value” that equates to a roughly $10 million return on a $2 million investment for phase 2 trials and $39 million return on a $3 million investment for phase 3 studies. The economic savings come from reduced cycle times, improved patient screening and enrollment, and fewer protocol amendments over the life of a trial.
    Full story
  • Worldwide Clinical Trial, Invitae Announce RWD Platform Partnership

    Jul 12, 2022, 10:20 by User Not Found
    Clinical Research News | Worldwide Clinical Trials and Invitae have announced a strategic partnership. Worldwide will be the first CRO to use Invitae’s Explorer tool, part of its real-world data platform that enables access to aggregated genetic testing results.
    Full story
  • BioIVT Launches New Scientific Advisory Board

    Jul 12, 2022, 09:43 by
    Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.
    Full story
  • How the World’s First Clinical Trial Market Network Saves Stakeholders Time and Money

    Jul 12, 2022, 01:00 by User Not Found
    Clinical Research News | ClinEco–a clinical trial ecosystem and market network designed to streamline the process of identifying and selecting clinical trial partners–is the first of its kind. It reduces the cost and speed of studies by catering to the specific needs of individual sponsors and vendors.
    Full story
  • Celegence adds report writing functionality to EU MDR & IVDR compliance technology CAPTIS™ to help streamline medical writing and document maintenance

    Jul 11, 2022, 09:57 by
    Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.
    Full story
  • 3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

    Jul 11, 2022, 09:54 by
    Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide.
    Full story
  • RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment

    Jul 8, 2022, 09:45 by
    Rapid, adaptive radiotherapy treatment plans hold potential to reduce toxicity and improve patient outcomes
    Full story
  • Oncology news: Capnopharm announces asset purchase of Capnomed as PIPAC™ shows superiority over IV Chemotherapy in first randomised data presented at ASCO 2022

    Jul 7, 2022, 09:19 by
    Capnopharm GmbH today announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.
    Full story
  • Drug Repurposing Strategy Without An ‘Answer Book’

    Jul 7, 2022, 01:00 by User Not Found
    Clinical Research News | Scientists working in the information biology lab at Hokkaido University in Japan have come up with a drug repurposing strategy combining machine learning, unsupervised clustering of gene expression, and two-stage prediction.
    Full story
  • Vaccizone selects Exothera for process development and GMP manufacturing of its SARS‑CoV‑2 vaccine based on proprietary ASC technology

    Jul 6, 2022, 09:24 by
    Vaccizone has selected Exothera S.A. to fast-track process development of its SARS‑CoV‑2 vaccine for European clinical trials.
    Full story
  • DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

    Jul 5, 2022, 09:48 by
    DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
    Full story
  • CD Formulation Enlarges Particulate Matter Testing Capability

    Jul 5, 2022, 09:47 by
    Full story
  • A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer

    Jul 5, 2022, 09:46 by
    Full story
  • BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package

    Jul 5, 2022, 09:45 by
    Full story
  • BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

    Jul 5, 2022, 09:45 by
    Full story
  • BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

    Jul 5, 2022, 09:45 by
    Full story
  • BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

    Jul 5, 2022, 09:45 by
    Full story
  • «
  • 111
  • 112
  • 113
  • 114 (current)
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »